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Perfluorinated compounds (PFCs) have been detected in many environmental matrices, biota, and nonoccupationally exposed 
populations in China recently. However, little is known about the distribution and levels of various PFCs in the general population 
living in areas where there is PFC exposure. In the present study, the levels and prevalence of ten target PFCs were determined in 
227 serum samples from a population of nonoccupationally exposed individuals in Shenzhen, China. Results indicated that human 
exposure to PFCs was prevalent in Shenzhen. Perfluorooctanoate (PFOA) was the dominant PFC contaminant in the serum sam-
ples, with a median concentration of 6.72 ng/mL, followed by perfluorooctane sulfonate (PFOS) with a median concentration of 
2.07 ng/mL. Other PFCs were detected at much lower concentrations, with median concentrations ranging from 0.02 to 0.87 
ng/mL. Statistically, no significant (P>0.05) gender differences were observed for any of the PFCs. Significant (P<0.01) positive 
correlations were found between age and serum concentrations of the target PFCs, except for perfluorobutane sulfonate (R = 0.16, 
P = 0.01), perfluorohexanoic acid (R = 0.08, P = 0.22), and perfluoroheptanoic acid (R = 0.11, P = 0.10). Based on the 
one-compartment pharmacokinetic model, the total daily intakes of PFOA and PFOS for the general population in Shenzhen were 
calculated as 0.63 and 0.20 ng/kg body weight/day, respectively.  
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Since the 1950s, perfluorinated compounds (PFCs) have 
been produced and used in multiple industrial and consumer 
products, such as protective coatings for fabrics and carpet, 
paper coatings, paints, adhesives, cosmetics, pharmaceuti-
cals, insecticide formulations, fire retardants and surfactants 
[1]. PFCs have unique physicochemical characteristics such 
as thermal and chemical stability, amphiphilicity, low sur-
face free energy and surface active properties [2]. The most 
commonly studied PFCs are perfluorooctane sulfonate 
(PFOS) and perfluorooctanoate (PFOA), and these two 
compounds have been detected in various environmental 
matrices and biota, as well as occupationally and nonoccu-
pationally exposed populations around the world. Because 
of their global distribution [3], bioaccumulation [4], toxicity 
[5], and the potential for transportation into remote regions, 
these compounds have received much attention internation-
ally [6]. As a direct consequence, 3M (St. Paul, MN), which 
is the primary global manufacturer of fluorochemicals, an-
nounced in 2000 that they would phase out the production 
of PFOS and PFOS-based products by the end of   2002 [7]. 
Subsequently, the U.S. [8], the European Union [9] and 
Canada [10] established new rules and guidelines to regu-
late the production and use of PFOS and its related sub-
stances. Recently, PFOS was added to Annex B of the 
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Stockholm Convention on Persistent Organic Pollutants 
(POPs) [11], which calls for restricted use of specified 
compounds worldwide. 
Previous studies on PFCs in China have mainly focused 
on water bodies [12,13], sediment [14], precipitation [15], 
biota [16] and nonoccupationally exposed populations 
[17,18]. Until now, there has been limited information 
available on PFCs in the general population in China to 
PFCs, and especially on the distribution and levels of vari-
ous PFCs in the general population living in areas of China 
where there is exposure to PFCs. 
The potential exposure sources and pathways of PFCs for 
the general population include through food [19], drinking 
water [20,21], dust, and indoor/outdoor air [22]. Dietary 
intake is regarded as the most important exposure pathway 
for the general population [23]. Drinking water is also an 
important source of exposure to PFCs contamination, and 
many studies have investigated PFCs levels in populations 
resulting from contaminated drinking water [20,21]. 
One study from Germany found that the concentrations 
of PFCs in plasma from children and adults exposed to 
PFCs increased 4- to 8-fold in comparison with the controls 
because of consumption of contaminated drinking water 
[20]. Similar results were also obtained in the U.S. [21]. In 
view of the safety of drinking water, the U.S. Environmen-
tal Protection Agency issued provisional health advisories 
for PFOA and PFOS in drinking water at 400 and 200 ng/L, 
respectively, in 2009 [24]. To our knowledge, no regulatory 
drinking water threshold values have been recommended 
for PFCs in China. A previous study found the drinking 
water in Shenzhen of China contained elevated levels of 
PFOS (mean 11 ng/L), which were at least 2- to 420-fold 
higher than those found in the other areas of China [25]. 
The median level of PFOA in the drinking water exceeded 
40 ng/mL [26], which might have adverse effects on the 
health of consumers in this PFC-exposed area [27]. 
Shenzhen, the first Chinese Special Economic Zone, is 
located in the Pearl River Delta of South China, which has 
experienced extremely rapid economic development over 
the past few decades. In 2009, this area was ranked fourth in 
China for total GDP, and ranked first for GDP per capita. 
There are a wide range of industrial activities in this area 
that could use PFCs, such as production of electron-
ic/electric equipment and machinery, petrochemicals, 
pharmaceuticals, plastic goods and textiles. These activities 
could potentially release of PFCs into the environment. 
Some studies of surface water, drinking water, and sediment 
in Shenzhen have found higher levels of PFCs than in other 
areas of China [12,14,25,26]. However, information on the 
PFCs load in the human and related health risks in this 
heavily contaminated area is limited. 
In the present study, the levels and prevalence of ten 
PFCs were determined in serum samples from the nonoc-
cupationally exposed population in Shenzhen of China. The 
aims of this study were to evaluate the PFCs background 
levels that the local general population are exposed to, as-
sess gender- and age-related differences in the serum PFCs 
concentrations, and estimate if drinking water could be an 
important exposure pathway for PFCs in Shenzhen. This 
data could be used for a human health risk assessment for 
the general population living in PFC-contaminated areas in 
China. 
1  Materials and methods 
1.1  Sample collection 
In collaboration with the Shenzhen Center for Disease Con-
trol, 227 serum samples were collected in 2009 by veni-
puncture from nonoccupationally exposed individuals in 
Shenzhen, China. The participants were 0.3 to 90 years old, 
and all except for the infants and toddlers had lived in 
Shenzhen for >5 years. There were 133 males (mean age 
32±30 years) and 94 females (mean age 38±31 years), and 
there was no significant difference (P>0.05) between their 
ages. Samples were void of personal identifiers, and the 
known demographic factors such as age, gender, sampling 
location, and date of collection. Serum samples were stored 
in methanol-rinsed polypropylene containers at –20°C. 
1.2  Reagents and chemicals 
Potassium PFOS (purity 98%) was purchased from Fluka 
(Steinheim, Germany). Potassium perfluorobutane sulfonate 
(PFBS, purity 98%), undecafluorohexanoic acid (PFHxA, 
purity 98%), tridecafluoroheptanoic acid (PFHpA, purity 
98%), and hepatadecafluoropelargonic acid (PFNA, purity 
95%) were purchased from Tokyo Chemical Industry (To-
kyo, Japan). Potassium perfluorohexane sulfonate (PFHxS, 
purity 98%) was acquired from Interchim (Montlucon, 
France). Perfluorotetradecanoic acid (PFTA, purity 97%) 
was acquired from Sigma-Aldrich Chemie GmbH (Steinheim, 
Germany). Pentadecafluorooctanoic acid (PFOA, purity 95%) 
was obtained from Wako Pure Chemical Industries (Osaka, 
Japan). Nonadecafluorodecanoic acid (PFDA, purity 96%) 
and perfluorododecanoic acid (PFDoA, purity 97%) were 
acquired from Acros Organics (Geel, Belgium). High-  
performance liquid chromatography (HPLC) grade tetrabu-
tylammonium hydrogen sulfate and anhydrous extra pure 
sodium carbonate (Na2CO3, purity 99.5%) were obtained 
from Acros Organics (Geel, Belgium). HPLC grade ammo-
nium acetate was obtained from Dikma Technology (Rich-
mond, VA, USA). HPLC grade methyl tert-butyl ether 
(MTBE), methanol, and acetonitrile were obtained from 
Tedia (Fairfield, OH). Milli-Q water was cleaned using 
Waters Oasis HLB Plus cartridges (Milford, MA, USA) to 
remove potential PFCs residues. A mixed stock standard 
solution of PFCs was prepared in methanol. All reagents 
were used as received. All the equipment used in the study 
was pre-cleaned with methanol and then Milli-Q water. No 
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Teflon and glass equipment was used in the experiment. 
1.3  Sample preparation and extraction 
Serum samples were extracted using the method described 
by Hansen et al. [28]. Briefly, 0.5 mL of serum, 2 mL of 
Na2CO3 (0.25 mol/L), and 1 mL of tetrabutylammonium 
hydrogen sulfate (0.5 mol/L) were added to a 15 mL 
pre-washed polypropylene tube for extraction and mixed 
well. MTBE (5 mL) was then added to the solution, and the 
mixture was shaken for 20 min. The organic and aqueous 
layers were separated by centrifugation at 3000 r/min for 15 
min, and the organic layer was transferred to a second poly-
propylene tube. The aqueous layer was extracted again with 
MTBE, and the organic layer was separated and combined 
with that from the first extraction. The combined MTBE 
extracts were evaporated to dryness under high purity ni-
trogen, and then the residue was reconstituted in 1 mL of a 
mixture of methanol and 10 mmol/L ammonium acetate 
(2:3, v/v). Finally, the sample was filtered through a 0.22 
μm nylon filter. 
1.4  Instrumental analysis 
The PFCs concentrations in the serum samples were ana-
lyzed using HPLC-tandem mass spectrometry (HPLC- 
MS/MS). Chromatography was performed on an Agilent 
1100 HPLC system (Agilent Technologies, Palo Alto, CA). 
A 25 μL aliquot of the extract was injected onto a Agilent 
Eclipse Plus C18 column (100 mm × 2.1 mm I.D., 3.5 μm 
particle size, Agilent Technologies, Palo Alto, CA). The 
column temperature was 40°C. The mobile phase was a 
mixture of 10 mmol/L ammonium acetate and acetonitrile at 
a flow rate of 0.25 mL/min. The mobile phase gradient 
started at 40% acetonitrile, increased to 90% acetonitrile at 
9 min, and was held at this level for 2 min. The system was 
allowed to equilibrate for 8 min between injections. The 
HPLC system was interfaced to an Agilent 6410 Triple 
Quadruple mass spectrometer (Agilent Technologies, Santa 
Clara, CA) operated in negative electrospray ionization (ESI) 
mode. The dry gas temperature and ion spray voltage were 
maintained at 350°C and 4000 V. The dry gas flow and 
nebulizer pressure were 7 L/min and 35 psi (1 psi = 6.895 
kPa), respectively.  
1.5  Quality assurance and quality control 
During the analysis, procedural blanks were prepared and 
analyzed after every 10 samples to check if contamination 
occurred during the preparation of samples. Solvent blanks 
containing acetonitrile and Milli-Q water (2:3, v/v) were 
prepared and analyzed after every 20 samples to monitor 
instrumental background contamination. Duplicate injec-
tions and calibration check standards were run after every 
20 samples to ensure the precision and accuracy of each run. 
The concentrations of serum extracts were quantified via 
nine-point matrix-matched calibration curves constructed 
from 0.01 to 100 ng/mL by adding the mixed PFC standard 
solution into newborn bovine serum (HyClone, Logan, 
Utah). The limit of detection (LOD) was defined as the an-
alyte concentration required produce a signal-to-noise (S/N) 
ratio of 3:1, and the limit of quantification (LOQ) was de-
fined as the lowest point on the standard curve, above the 
LOD, that had a relative standard deviation (RSD) <20%. 
The LODs for the ten target PFCs ranged from 0.01 to 0.02 
ng/mL, while the LOQs ranged from 0.03 to 0.05 ng/mL. 
The recovery and reproducibility of the serum sample ex-
traction were determined on six replicate analyses of 0.5 mL 
of newborn bovine serum containing 2 ng of each PFC 
standard. No PFC contamination was found above the LOD 
in newborn bovine serum. Recoveries of all the PFCs ana-
lytes were between (82±6)% and (101±6)%. 
1.6  Modeling of exposure based on serum PFCs levels 
In this study, the daily intake of PFOA and PFOS in the 
general population in Shenzhen was estimated based on 
serum PFC concentrations with a simple one-compartment 
pharmacokinetic model [19,29,30]. The change in blood 
concentration (Cp) resulting from a given exposure dose (E) 
can be described by the following equation: 
 d(Cp)/dt = E – k × Vd × Cp,  (1) 
where Vd is the volume of distribution (mL/kg bw); and k is 
the first-order elimination per day, which is equal to 
0.693/t1/2 under steady-state conditions. In the case where 
d(Cp)/dt = 0, this equation becomes 
 E = k × Vd × Cp, (2) 
and 
 E = 0.693/t1/2 × Vd × Cp. (3) 
In agreement with previous studies, the median half-life of 
PFOA and PFOA were 1257 and 1661 d [31], respectively. 
The volume of distribution of PFOA and PFOS were 170 
and 230 mL/kg (bw) [29], respectively. 
1.7  Statistical analysis 
Statistical analyses were performed with SPSS 16.0 (SPSS 
Inc., Chicago, IL). Concentrations lower than the LOD and 
the LOQ were assigned a value of half of the LOD and 
LOQ, respectively. Differences among the serum PFCs lev-
els in different gender and age groups were evaluated using 
the Mann-Whitney test. The Spearman’s rank correlation 
was applied to assess the relationships between age and the 
PFCs levels in serum, and among various PFCs in the sam-
ples. All the differences and correlations were considered to 
be significant at P<0.05. 
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2  Results and discussion 
The serum PFCs levels of all the participants, stratified by 
gender, are given in Table 1. PFOS and PFOA were detect-
ed in all of the samples analyzed. The frequency of detec-
tion of the other target PFCs was in the order PFNA> 
PFHpA>PFHxS>PFDA>PFBS>PFHxA>PFDoA>PFTA. 
These results indicate that exposure to PFCs was wide-
spread in the general population of Shenzhen. PFOA had 
the highest median concentration of 6.72 ng/mL (range 0.30 
to 48.4 ng/mL), followed by PFOS (median 2.07 ng/mL, 
range 0.10 to 40.0 ng/mL). The other target PFCs were de-
tected at much lower levels, with median concentrations 
ranging from 0.02 to 0.87 ng/mL.  
The PFCs concentrations in the present study were com-
parable to those from previously studies (Table 2). For the 
purpose of comparison, the PFCs concentrations in whole 
blood were converted into serum PFCs concentrations by 
multiplying by a factor of 2 [32]. The median serum PFOA 
concentration in Shenzhen was slightly higher than those 
observed in North America [33,34], Belgium [32], Italy [35], 
Japan [36], and other areas of China [17,18,30,37,38], and 
similar to the median concentrations detected in Australia 
[39] and Germany [40]. However, it was much lower than 
those from PFC-contaminated regions in the U.S. [21] (374 
ng/mL) and Germany [20] (>20 ng/mL). The median con-
centrations of PFOS (2.1 ng/mL) and PFHxS (0.46 ng/mL) 
in the current study were considerably lower than those re-
ported in North America [33,34], Europe [32,41], Australia 
[39,42] and some other regions in China (14.8–35.8 ng/mL 
for PFOS, 1.3–6.2 ng/mL for PFHxS) [17,18]. The 
long-chain perfluorocarboxylate, PFNA, was detected in 
most of the serum samples, and its median concentration 
(0.87 ng/mL) was comparable to those found in Australia 
[39] (0.8 ng/mL) and the U.S. [33] (0.6 ng/mL). 
2.1  Gender- and age-related differences in serum PFC 
levels 
To evaluate possible gender and age influences on the se-
rum PFCs concentrations, serum samples were stratified 
into four different groups according to the age of the indi-
vidual (<5, 5–13, 14–60, and >60 years) and the gender. 
The age groups were established based on the enrollment 
age for children (5–6 years), the average age of menarche 
(13 years), and the maximum retirement age of the general 
population (60 years). 
The concentrations for each PFC in the serum samples 
stratified by gender are given in Table 1. In general, no sta-
tistically significant differences were found for any of the 
PFCs between genders. However, the median concentra-
tions of PFOA, PFOS, PFNA and PFHxS were slightly  
Table 1  PFCs concentrations (ng/mL) in serum samples from Shenzhen residents stratified by gender a) 
Gender No.  PFBS PFHxS PFOS PFHxA PFHpA PFOA PFNA PFDA PFDoA PFTA 
Male 133 Detection (%) 37.6 80.5 100 26.3 87.2 100 97 45.1 24.1 22.6 
  GM 0.05 0.39 2.07 0.04 0.18 6.41 0.75 0.12 0.05 0.03 
  Min ND   ND 0.10   ND   ND 0.43   ND   ND   ND ND 
  25th 0.02 0.11 0.48 0.02 0.12 3.66 0.53 0.03 0.03 0.02 
  Median 0.02 0.42 1.88 0.02 0.22 6.53 0.87 0.03 0.03 0.02 
  75th 0.08 1.81 10.9 0.12 0.36 12.1 1.36 0.48 0.03 0.02 
  Max 9.97 13.2 39.5 1.64 1.78 42.9 7.05 3.58 1.57 0.54 
Female 94 Detection (%) 51.1 75.5 100 27.7 86.2 100 96.8 51.1 24.5 21.3 
  GM 0.06 0.32 2.28 0.04 0.16 6.33 0.63 0.13 0.05 0.03 
  Min   ND   ND 0.13   ND   ND 0.30   ND   ND   ND ND 
  25th 0.02 0.04 0.45 0.02 0.10 3.24 0.42 0.03 0.03 0.02 
  Median 0.03 0.49 2.39 0.02 0.19 7.64 0.88 0.15 0.03 0.02 
  75th 0.20 1.35 11.4 0.11 0.36 13.0 1.29 0.52 0.05 0.02 
  Max 7.72 14.9 40.0 2.36 1.14 48.4 6.17 2.24 0.53 0.56 
  P 0.04 0.59 0.78 0.94 0.25 0.85 0.42 0.61 0.91 0.87 
Total 227 Detection (%) 43.2 78.4 100 26.9 86.8 100 96.9 47.6 24.2 22 
  GM 0.05 0.36 2.15 0.00 0.17 6.38 0.70 0.12 0.05 0.00 
  Min   ND   ND 0.10   ND   ND 0.30   ND   ND   ND ND 
  25th 0.02 0.08 0.45 0.02 0.11 3.54 0.49 0.03 0.03 0.02 
  Median 0.02 0.46 2.07 0.02 0.20 6.72 0.87 0.03 0.03 0.02 
  75th 0.13 1.58 11.2 0.11 0.36 12.5 1.31 0.52 0.03 0.02 
  Max 9.97 14.9 40.0 2.36 1.78 48.4 7.05 3.58 1.57 0.56 
a) No., the number of participants; Detection, the frequency of detection; GM, geometric mean; ND, not detected; the significance of the difference (P)  
between genders was determined by the Mann-Whitney test. 
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Table 2  Comparison of median (range) concentrations (ng/mL) of selected perfluorinated compounds in human serum/plasma from several countries  
Area PFOA PFOS PFNA PFHxS No. Year sampled Reference 
Asia/Pacific        
China 6.72 (0.30–48.4) 2.07 (0.10–40.0) 0.87 (ND–7.05) 0.46 (ND–14.9) 227 2009 Present study 
 4.3 (0.20–60) 22.4 (0.20–145) – – 119 2002 [18] 
 1.01b) (0.05–76.26) 5.58b) (0.41–33.47) – 1.47b) (0.12–25.23) 138 2008 [37] 
 1.59a) 52.7a) – 1.88a) 85 2004 [17] 
Japan  2.8–12.4c) 3.5–28.1c) – – 205 2003 [36] 
Australia 6.4 (0.8–9.1) 14.8 (5–28.5) 0.8 (0.1–1.4) 2.9 (<0.1–11.3) 84e) 2006–2007 [39] 
 7.6 (5.0–9.9) 20.8 (12.7–29.5) 1.1 (0.4–2.0) 6.2 (2.7–19.0) 40d) 2002–2003 [42] 
North America        
USA  5.1 30.2 0.6 2.1 1562 1999–2000 [43] 
 4.7 (<1.9–52.3) 35.8 (<4.3–1656) – 1.5 (<1.4–66.3) 645 2000–2001 [34] 
 (<3–88)a) (<1.3–164)a) – (<0.4–32)a) 175 2000–2002 [32] 
Europe        
Belgium 4.1 (1.1–12.8) 17.2 (4.5–27) – 1.3 (1.1–1.4) 20 1998, 2000 [32] 
Sweden 5.0a) (1.0–24.8) 34.2a) (3.4–74) – 3.0a) (0.8–56.8) 66 1997–2000 [41] 
Germany  6.8 (1.7–39.3) 22.3 (6.2–131) – – 105 2005 [40] 
Poland  (9.7–40)a) (16–116)a) – (<0.4–2.6)a) 25 2003 [32] 
a) Calculated from the concentration in whole blood by multiplying by a factor of 2; b) geometric mean; c) range of the geometric means of different 
regions; d) forty pooled samples were created from 3802 individual samples; e) Eighty-four pooled samples were created from 2420 individual samples. 
 
 
higher in females than in males (P>0.05). The PFC concen-
trations for males and females were similar concentrations 
in the four age groups. The lack of a gender difference in-
dicates that menses did not affect the PFC concentrations in 
the 14–60 years old participants, which is consistent with 
the results from previous studies [37]. A recent study on 
serum concentrations of PFCs in the general population 
from Liaoning Province, China did not find any significant 
differences between the genders [37]. Similarly, no signifi-
cant differences between males and females were reported 
by Corsolini and Kannan for the concentrations of PFOS, 
PFHxS, and PFOA in serum samples from Italy [35], the 
U.S. and Colombia [32]. However, significantly higher 
concentrations of PFOS were detected in serum samples 
from females than those from males in Japan [36], and in 
Poland higher concentrations were detected in samples from 
males compared to the samples from females [32]. Signifi-
cant gender-related differences were also reported in the 
U.S. and Australia [33,39,43]. 
For all the participants in this study (0.3–90 years), a sig-
nificant positive correlation was observed between age and 
the serum concentrations of the PFCs, except for PFBS, 
PFHxA and PFHpA. The serum concentration of PFBS 
showed a significant negative correlation with age, and no 
significant correlations were observed between age and the 
concentrations of PFHxA and PFHpA. Furthermore, the 
ages of both genders showed significant positive correla-
tions with the levels of PFOS, PFOA and PFHxS (Table 3). 
Significant correlations of serum PFCs with age were also 
reported in other studies [21,38,44]. In a Chinese study, the 
PFOS and PFHxS concentrations increased significantly 
with age, while the concentration of PFOA showed a nega-
tive correlation with age [38]. Two studies from Germany 
also found an age-related accumulation in serum PFCs. One 
investigation observed the phenomenon in females [44]. In 
the other study, the positive correlation was observed for 
males with PFOS, PFOA and PFHxS in plasma, while for 
females it was observed with PFOA only [21]. 
These results illustrate a lack of consistency between 
studies for gender- and age-related differences in PFCs 
concentrations in human blood samples. This may be at-
tributed to confounding factors, such as occupation, lifestyle, 
history of exposure, elimination half-life, and some physio-
logical factors of the subjects, method parameters, including 
sample size, and detection rate of the target analyte. Lacta-
tion, pregnancy [45], and menstruation have been hypothe- 
Table 3  Spearman’s rank correlation coefficients between age and serum PFCs concentrations 
 PFBS PFHxS PFOS PFHxA PFHpA PFOA PFNA PFDA PFDoA PFTA 
Male 0.25a) 0.41a) 0.43a) 0.02 0.18b) 0.24a) 0.16 0.55a) 0.36a) 0.33a) 
Female 0.08 0.49a) 0.37a) 0.20 0.01 0.35a) 0.37a) 0.42a) 0.26b) 0.16 
Total 0.16b) 0.44a) 0.41a) 0.08 0.11 0.29a) 0.24a) 0.50a) 0.32a) 0.26a) 
a) Correlation is significant at the 0.01 level (2-tailed); b) correlation is significant at the 0.05 level (2-tailed). 
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sized as important PFCs elimination routes for premeno-
pausal adult females in some studies [46]. The decrease in 
serum PFBS levels with age could result from the faster 
serum elimination rate of PFBS compared to long-chain 
PFCs [47]. 
The correlation between the PFCs serum levels and age 
in the various age groups was not consistent (Figure 1). The 
serum concentrations of PFOA and PFHxS increased with 
age in the four groups. With PFOS, the concentration in-
creased with age in the groups of individuals <60 years old, 
and then decreased at >60 years. For PFOA, PFOS, PFHxS 
and PFNA the concentrations in the groups aged <13 years 
were much lower than those in the group aged >60 years. 
Significantly higher serum concentrations of PFOS, PFHxS 
and PFNA were observed in the 14–60 years group, com-
pared with those in the <13 years groups. Overall, the serum 
concentrations of PFCs in the 14–60 and >60 years groups 
were significantly greater than those in the <13 years groups, 
which suggests these compounds accumulate with age. 
These results were not consistent with some earlier studies, 
in which higher levels of PFCs were found in children than 
in adults [30,39]. Those findings suggested that contact with 
carpeted floors and furniture, hand-to-mouth activity, inges-
tion of dust [22], breast milk [45], and transplacental 
movement of PFCs from the mother to the child [48] might 
contribute to the higher PFC concentrations in children. 
Furthermore, the concentrations of PFOS decreased in 
the >60 years group compared with those in the 14–60 years 
group. Further studies needed to be carried out to determine 
the reason for this. 
2.2  Correlations among serum levels of PFCs analogues  
The Spearman’s rank correlation coefficients among the 
different PFCs were examined. Significant  positive corre-
lations (P<0.01) between PFOS and PFHxS, PFOA and 
PFHxS, PFNA and PFHxS, and PFOS and PFNA were 
found. In addition, significant positive correlations were 
found among PFOA, PFDA, PFDoA, PFTA and PFNA, 
which suggests there is a common exposure pathway for 
these long-chain PFCAs in Shenzhen. However, PFDoA 
and PFTA were negatively correlated to PFHpA and PFOA, 
respectively (P<0.01). In general, the correlations found in 
the present study showed similar sources of exposure for 
PFCs in this region. 
2.3  Modeling of daily intake of PFCs by the general 
population in Shenzhen 
The one-compartment toxicokinetic model and the measured  
 
 
Figure 1  Serum concentrations of PFOA (a), PFOS (b), PFNA (c), and PFHxS (d) in four age groups of the general population in Shenzhen, China. The 
box plots show the 25th percentile, median, and 75th percentile, and the error bars indicate the minimum and maximum values. The results presented were 
calculated after excluding outliers.
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serum PFC concentrations from the present study were used 
to estimate the daily intake of PFOA and PFOS for the gen-
eral population in Shenzhen. The median concentrations of 
PFOA and PFOS in serum samples from Shenzhen were 6.7 
and 2.1 ng/mL, respectively, and the total daily intakes of 
PFOA and PFOS for the general population in Shenzhen 
were calculated as 0.63 and 0.20 ng/kg(bw), respectively. 
The estimated total daily intake of PFOA in the present 
study was higher than that in Fuxin, China (0.40 ng/kg(bw)), 
where several fluorochemical plants exist [30]. However, 
the total daily intake of PFOS was lower than that in Nan-
chang, China (0.74 ng/kg(bw) for males, 1.2 ng/kg(bw) for 
females) [38]. In comparison with developed countries, the 
estimated total daily intakes of PFOA and PFOS in Shen-
zhen were much lower than those in Australia (PFOA, 1.3 
ng/kg(bw); PFOS, 2.4 ng/kg(bw)) [29].  
Median concentrations of PFOA and PFOS in drinking 
water from Shenzhen have been reported as 45.9 and 14.8 
ng/mL, respectively [26]. Mean concentrations of 1 ng/mL 
(PFOA) and 11 ng/mL (PFOS) have also been reported [25]. 
These data were used to calculate daily intakes of PFOA 
and PFOS from drinking water by assuming an average 
body weight of 60 kg [49] and a drinking water intake of  
2 L. The daily intakes from drinking water for the general 
population in Shenzhen were calculated to be 1.53 and 0.03 
ng/kg(bw) for PFOA, and 0.37 and 0.49 ng/kg(bw) for 
PFOS. From these values, it was estimated the consumption 
of drinking water in Shenzhen contributes 243% or 5% of 
the total PFOA, and 245% or 185% of the total PFOS. The-
se estimated contributions of drinking water to PFCs expo-
sure in Shenzhen were much higher than that estimated for 
the general European population (16%), which suggests 
drinking water might be a major PFCs source in this city.  
However, there were some limitations to the estimation 
of the contribution of drinking water, because the calcula-
tion was based on data from studies which only single col-
lection for each sample was taken for monitoring of water 
quality. Because the concentrations of PFOA and PFOS in 
drinking water could vary with time, these estimates might 
not provide a real-life reflection of the drinking water ex-
posure over a long time. This could explain the differences 
in the estimated contributions for drinking water using the 
data from the two different studies. Therefore, continuous 
monitoring of drinking water is required to accurately eval-
uate the exposure to PFCs from this source. Further research 
is needed to investigate the potential sources of human ex-
posure to PFCs in Shenzhen. 
3  Conclusions 
In summary, the results from this study indicate that human 
exposure to PFCs is prevalent in Shenzhen. Among the 10 
target PFCs, PFOA was the major compound detected in the 
serum samples from the general population living in Shen-
zhen. The results were consistent with those for drinking 
water from this area. Estimated total daily intakes of PFOA 
and PFOS for the general population in Shenzhen were 0.63 
and 0.20 ng/kg(bw), respectively, and were much lower 
than those found an earlier study in Australia. However, the 
contribution from drinking water was estimated to be much 
higher than that estimated in an earlier study for the general 
European population (16%), which suggests that drinking 
water may be a major source of PFC exposure in Shenzhen. 
Because of the persistence of PFCs, legacy sources will 
continue to contribute a constant, low-level exposure to 
PFCs for many years. Therefore, further studies are required 
to understand the sources and pathways of PFC exposure 
for the general population in Shenzhen, and assess the po-
tential human health risk for the local population. 
This work was supported by the National Science & Technology Pillar 
Program (2006BAI06B02) and the Program for Changjiang Scholars and 
Innovative Research Team in University (IRT0813). 
1 Organization for Economic Co-operation and Development. Co-  
operation on existing chemicals. Hazard assessment of perfluorooctane 
sulfonate (PFOS) and its salts, ENV/JM/RD17/FINAL, Paris, 2002 
2 Kissa E. Fluorinated Surfactants and Repellents. 2nd ed. Marcel 
Dekker: New York, 2001 
3 Giesy J P, Kannan K. Global distribution of perfluorooctane sul-
fonate in wildlife. Environ Sci Technol, 2001, 35: 1339–1342 
4 Martin J W, Whittle D M, Muir D C G, et al. Perfluoroalkyl contam-
inants in a food web from Lake Ontario. Environ Sci Technol, 2004, 
38: 5379–5385 
5 Lau C, Anitole K, Hodes C, et al. Perfluoroalkyl acids: A review of 
monitoring and toxicological findings. Toxicol Sci, 2007, 99: 366–394 
6 Martin J W, Smithwick M M, Braune B M, et al. Identification of 
long-chain perfluorinated acids in biota from the Canadian Arctic. 
Environ Sci Technol, 2004, 38: 373–380 
7 3M Company. Phase-out plan for POSF-based products, U.S. Envi-
ronmental Protection Agency Public Docket AR-226-0588. U.S. EPA, 
St.Paul, MN, 2000 
8 United States Environmental Protection Agency. Perfluorooctane 
sulfonate: proposed significant new use rule. Fed Reg, 2000, 65: 
62319–62333 
9 European Union. Directive 2006/122/ECOF of the European Parlia-
ment and of the Council of 12 December 2006. Official J Eur Union, 
L/372/3234, 2006 
10 Environment Canada. Order Adding Toxic Substances to Schedule 1 
to the Canadian Environmental Protection Act, 1999. Can Gaz Part II. 
2006,140: 2147–2153 
11 Stockholm Convention on Persistent Organic Pollutants. Governments 
unite to step-up reduction on global DDT reliance and add nine new 
chemicals under international treaty. Geneva: Stockholm Convention 
Secretariat, 8 May 2009. http://chm.pops.int/Convention/Pressrelease/ 
COP4Geneva8May2009/tabid/542/language/en-US/Default.aspx 
12 So M K, Taniyasu S, Yamashita N, et al. Perfluorinated compounds 
in coastal waters of Hong Kong, South China, and Korea. Environ 
Sci Technol, 2004, 38: 4056–4063 
13 Ju X, Jin Y, Sasaki K, et al. Perfluorinated surfactants in surface, 
subsurface water and microlayer from Daliao coastal waters in China. 
Environ Sci Technol, 2008, 42: 3538–3542 
14 Bao J, Liu W, Liu L, et al. Perfluorinated compounds in urban river 
sediments from Guangzhou and Shanghai of China. Chemosphere, 
2010, 80: 123–130  
15 Liu W, Jin Y, Quan X, et al. Perfluorosulfonates and perfluorocar-
 Li X, et al.   Chinese Sci Bull   October (2011) Vol.56 No.28-29 3099 
boxylates in snow and rain in Dalian, China. Environ Int, 2009, 35: 
737–742 
16 Li X, Yeung L W Y, Taniyasu S, et al. Perfluorooctane sulfonate and 
related fluorochemicals in the Amur Tiger (Panthera tigris altaica) 
from China. Environ Sci Technol, 2008, 42: 7078–7083 
17 Yeung L W Y, So M K, Jiang G, et al. Perfluorooctanesulfonate and 
related fluorochemicals in human blood samples from China. Environ 
Sci Technol, 2006, 40: 715–720 
18 Jin Y, Saito N, Harada K, et al. Historical trends in human serum 
levels of perfluorooctanoate and perfluorooctane sulfonate in Shen-
yang, China. Tohoku J Exp Med, 2007, 212: 63–70 
19 Fromme H, Schlummer M, Moller A, et al. Exposure of an adult 
population to perfluorinated substances using duplicate diet portions 
and biomonitoring data. Environ Sci Technol, 2007, 41: 7928–7933 
20 Holzer J, Midasch O, Rauchfuss K, et al. Biomonitoring of perfluori-
nated compounds in children and adults exposed to perfluorooctanoate- 
contaminated drinking water. Environ Health Perspect, 2008, 116: 651– 
657 
21 Emmett E A, Shofer F S, Zhang H, et al. Community exposure to 
perfluorooctanoate: relationships between serum concentrations and 
exposure sources. J Occup Environ Med, 2006, 48: 759–770 
22 Shoeib M, Harner T, Wilford B H, et al. Perfluorinated sulfonamides 
in indoor and outdoor air and indoor dust: Occurrence, partitioning, 
and human exposure. Environ Sci Technol, 2005, 39: 6599–6606 
23 Fromme H, Tittlemier S A, Völkel W, et al. Perfluorinated com-
pounds-exposure assessment for the general population in western 
countries. Int J Hyg Environ Health, 2009, 212: 239–270 
24 U.S. Environmental Protection Agency. Provisional Health Adviso-
ries for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate 
(PFOS), 2009. http://www.epa.gov/waterscience/criteria/drinking/pha- 
PFOA_PFOS.pdf 
25 Mak Y L, Taniyasu S, Yeung L W Y, et al. Perfluorinated com-
pounds in tap water from China and several other countries. Environ 
Sci Technol, 2009, 43: 4824–4829 
26 Jin Y, Liu W, Sato I, et al. PFOS and PFOA in environmental and tap 
water in China. Chemosphere, 2009, 77: 605–611 
27 Post G B, Louis J B, Cooper K R, et al. Occurrence and potential sig-
nificance of perfluorooctanoic acid (PFOA) detected in New Jersey 
public drinking water systems. Environ Sci Technol, 2009, 43: 4547– 
4554 
28 Hansen K J, Clemen L A, Ellefson M E, et al. Compound-specific, 
quantitative characterization of organic fluorochemicals in biological 
matrices. Environ Sci Technol, 2001, 35: 766–770 
29 Thompson J, Lorber M, Toms L M L, et al. Use of simple pharmaco-
kinetic modeling to characterize exposure of Australians to perfluo-
rooctanoic acid and perfluorooctane sulfonic acid. Environ Int, 2010, 
36: 390–397 
30 Bao J, Liu W, Liu L, et al. Perfluorinated compounds in the environ-
ment and the blood of residents living near fluorochemical plants in 
Fuxin of China. Environ Sci Technol, doi: 10.1021/es102610x 
31 Olsen G W, Burris J M, Ehresman D J, et al. Half-life of serum elimi- 
nation of perfluorooctanesulfonate, perfluorohexanesulfonate, per-
fluorooctanoate in retired fluorochemical production workers. Envi-
ron Health Perspect, 2007, 115: 1298–1305 
32 Kannan K, Corsolini S, Falandysz J, et al. Perfluorooctanesulfonate 
and related fluorochemicals in human blood from several countries. 
Environ Sci Technol, 2004, 38: 4489–4495  
33 Calafat A M, Kuklenyik Z, Reidy J A, et al. Serum concentrations of 
11 polyfluoroalkyl compounds in the US population: Data from the 
National Health and Nutrition Examination Survey (NHANES) 
1999–2000. Environ Sci Technol, 2007, 41: 2237–2242  
34 Olsen G W, Church T R, Miller J P, et al. Perfluorooctane sulfonate 
and other fluorochemicals in the serum of American Red Cross adult 
blood donors. Environ Health Perspect, 2003, 111: 1892–1901  
35 Corsolini S, Kannan K. Perfluorooctanesulfonate and related fluoro-
chemicals in several organisms including humans from Italy. Orga-
nohalogen Compd, 2004, 66: 4079–4085  
36 Harada K, Saito N, Inoue K, et al. The influence of time, sex and ge-
ographical factors on levels of perfluorooctane sulfonate in human 
serum over the last 25 years. J Occup Health, 2004, 46: 141–147  
37 Liu J Y, Li J G, Luan Y, et al. Geographical distribution of perfluori-
nated compounds in human blood from Liaoning Province, China. 
Environ Sci Technol, 2009, 43: 4044–4048 
38 Zhang T, Wu Q, Sun H W, et al. Perfluorinated compounds in whole 
blood samples from infants, children, and adults in China. Environ 
Sci Technol, 2010, 44: 4341–4347 
39 Toms L M L, Calafat A M, Kato K, et al. Polyfluoroalkyl chemicals 
in pooled blood serum from infants, children, and adults in Australia. 
Environ Sci Technol, 2009, 43: 4194–4199 
40 Midasch O, Schettgen T, Angerer J. Pilot study on PFOS and PFOA 
of the German general population. Int J Hyg Environ Health, 2006, 
209: 489–496 
41 Kärrman A, Van Bavel B, Järnberg U, et al. Levels of perfluoroalkyl-
ated compounds in whole blood from Sweden. Organohalogen 
Compd, 2004, 66: 4058–4062  
42 Kärrman A, Mueller J F, Van Bavel B, et al. Levels of 12 perfluori-
nated chemicals in pooled Australian serum, collected 2002–2003, in 
relation to age, gender, and region. Environ Sci Technol, 2006, 40: 
3742–3748 
43 Calafat A M, Wong L Y, Kuklenyik Z, et al. Polyfluoroalkyl chemicals 
in the, U.S. population: data from the National Health and Nutrition 
Examination Survey (NHANES) 2003-2004 and comparisons with 
NHANES 1999-2000. Environ Health Perspect, 2007, 115: 1596–1602 
44 Fromme H, Midasch O, Twardella D, et al. Occurrence of perfluori-
nated substances in an adult German population in southern Bavaria. 
Int Arch Occup Environ Health, 2007, 80: 313–319 
45 Kärrman A, Ericson I, Van Bavel B, et al. Exposure of perfluorinated 
chemicals through lactation: Levels of matched human milk and se-
rum and a temporal trend, 1996–2004, in Sweden. Environ Health 
Perspect, 2007, 115: 226–230 
46 Harada K, Inoue K, Morikawa A, et al. Renal clearance of perfluo-
rooctane sulfonate and perfluorooctanoate in humans and their spe-
cies-specific excretion. Environ Res, 2005, 99: 253–261 
47 Olsen G W, Chang S C, Noker P E, et al. A comparison of the phar-
macokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, 
and humans. Toxicology, 2009, 256: 65–74 
48 Inoue K, Okada F, Ito R, et al. Perfluorooctane sulfonate (PFOS) and 
related perfluorinated compounds in human maternal and cord blood 
samples: assessment of PFOS exposure in a susceptible population 
during pregnancy. Environ Health Perspect, 2004, 112: 1204–1207 
49 General Administration of Sport of China. Bulletin of the Second Na-
tional Fitness Survey of China, 2005
 
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
 
